Pathophysiology of the Peritoneal Membrane during Peritoneal Dialysis: The Role of Hyaluronan

Abstract EN

During peritoneal dialysis (PD), constant exposure of mesothelial cells to bioincompatible PD solutions results in the denudation of the mesothelial monolayer and impairment of mesothelial cell function.

Hyaluronan, a major component of extracellular matrices, is synthesized by mesothelial cells and contributes to remesothelialization, maintenance of cell phenotype, and tissue remodeling and provides structural support to the peritoneal membrane.

Chronic peritoneal inflammation is observed in long-term PD patients and is associated with increased hyaluronan synthesis.

During inflammation, depolymerization of hyaluronan may occur with the generation of hyaluronan fragments.

In contrast to native hyaluronan which offers a protective role to the peritoneum, hyaluronan fragments exacerbate inflammatory and fibrotic processes and therefore assist in the destruction of the tissue.

This paper will discuss the contribution of mesothelial cells to peritoneal membrane alterations that are induced by PD and the putative role of hyaluronan in these processes.